login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ANTARES PHARMA INC (ATRS) Stock News
NASDAQ:ATRS -
US0366421065
-
Common Stock
5.59
0 (0%)
Last: 5/23/2022, 8:12:09 PM
5.59
0 (0%)
After Hours:
5/23/2022, 8:12:09 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ATRS Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Benzinga
Looking Into Antares Pharma's Return On Invested Capital
3 years ago - By: Kahn Swick & Foti, LLC
ANTARES PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Antares Pharma, Inc. - ATRS
3 years ago - By: Kuznicki Law PLLC
ANTARES PHARMA INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Antares Pharma, Inc. - ATRS
3 years ago - By: Invezz
Antares Pharma Inc shares up 45% on Wednesday: how come?
3 years ago - By: InvestorPlace
- Mentions:
BCTX
PYPL
Why Is BriaCell (BCTX) Stock Moving Today?
3 years ago - By: Kahn Swick & Foti, LLC
ANTARES PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Antares Pharma, Inc. - ATRS
3 years ago - By: Benzinga
- Mentions:
BBBY
HYPR
PRM
WIX
...
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022
3 years ago - By: Weiss Law
- Mentions:
HALO
SHAREHOLDER ALERT: Weiss Law Investigates Antares Pharma, Inc.
3 years ago - By: InvestorPlace
- Mentions:
SRRA
GSK
HALO
GILD
Why Is Sierra Oncology (SRRA) Stock Up Today?
3 years ago - By: InvestorPlace
- Mentions:
HALO
PYPL
Why Is Antares Pharma (ATRS) Stock Up Today?
3 years ago - By: Investor's Business Daily
- Mentions:
GSK
SRRA
HALO
Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares
3 years ago - By: Halper Sadeh LLP
ATRS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Antares Pharma, Inc. Is Fair to Shareholders
3 years ago - By: InvestorPlace
- Mentions:
HALO
AGRX
SRRA
GSK
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
3 years ago - By: Halozyme Therapeutics, Inc.
- Mentions:
HALO
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
4 years ago - By: Antares Pharma, Inc.
Antares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating Results
Please enable JavaScript to continue using this application.
